Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00444587
Status:
COMPLETED
Last Update Posted:
2016-06-21
First Post:
2007-03-07
Brief Title:
A Study of Herceptin Trastuzumab in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer
Sponsor:
Organization:
Hoffmann-La Roche